Global Endowment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-82,478
Closed -$4.29M 230
2018
Q1
$4.29M Buy
82,478
+15,825
+24% +$855K 0.62% 27
2017
Q4
$3.58M Buy
66,653
+6,728
+11% +$373K 0.52% 31
2017
Q3
$3.66M Buy
59,925
+53,658
+856% +$3.25M 0.52% 28
2017
Q2
$383K Hold
6,267
0.05% 197
2017
Q1
$380K Hold
6,267
0.06% 193
2016
Q4
$352K Hold
6,267
0.05% 200
2016
Q3
$373K Hold
6,267
0.06% 154
2016
Q2
$345K Hold
6,267
0.07% 145
2016
Q1
$316K Hold
6,267
0.07% 161
2015
Q4
$316K Sell
6,267
-514
-8% -$25.9K 0.06% 154
2015
Q3
$320K Buy
+6,781
New +$360K 0.05% 186

Other funds holding MRK

Global Endowment Management's MRK Position: Q2 2018 in Review

Global Endowment Management sold out of Merck (MRK) in Q2 2018, closing a stake of 82,478 shares — an estimated $4.29M sold.

Global Endowment Management first reported a position in MRK in Q3 2015 and held it in 11 quarters. The position peaked at $4.29M in Q1 2018. 2,017 funds tracked by Wall St. Rank hold MRK as of Q2 2018.

  • Global Endowment Management reported no remaining Merck position as of Q2 2018 after selling out during the quarter.
  • Global Endowment Management sold 82,478 Merck shares in Q2 2018, an estimated $4.29M.
  • Global Endowment Management first reported a position in Merck in Q3 2015 and held it in 11 quarters.
  • Global Endowment Management's Merck position peaked at $4.29M in Q1 2018.
  • 2,017 funds tracked by Wall St. Rank held Merck as of Q2 2018.

Based on Global Endowment Management's 13F filing for Q2 2018, filed 10 Aug 2018.